Literature DB >> 1634040

Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene.

S S Sommer1.   

Abstract

Germline mutations cause or predispose to most disease. Hemophilia B is a useful model for studying the underlying pattern of recent germline mutations in humans because the observed pattern of mutation in factor IX more closely reflects the underlying pattern of mutation than the observed pattern for many other genes. In addition, it is possible to identify and correct for biases inherent in ascertaining only those mutations that cause hemophilia. Aspects of the pattern of germline mutation in the factor IX gene are becoming clear: 1) in the United States, two-thirds of mutations causing mild disease arose from three founders whereas almost all the mutations resulting in either moderate or severe disease arose independently, generally within the past 150 years; 2) direct estimates of the rates of mutation in humans indicate that transitions are more frequent than transversions, which in turn are more frequent than deletions and insertions; 3) transitions at CpG are elevated approximately 24-fold relative to transitions at non-CpG dinucleotides; 4) transversions at CpG are elevated approximately eightfold relative to transversions at non-CpG dinucleotides; 5) the sum total of the dinucleotide mutation rates produces a bias against G and C bases that would be sufficient to maintain the G+C content of the factor IX gene at its evolutionarily conserved level of 40%; and 6) the pattern of mutation is similar for Caucasians residing in the United States and for Asians residing in Asia. Two ideas emerge from this and from an analysis of the pattern of recent deleterious mutations compared with ancient neutral mutations that have been fixed during evolution into the factor IX gene. First, the bulk of germline mutations are likely to arise from endogenous processes rather than environmental mutagens. Second, the factor IX protein is composed mostly of two classes of amino acids: critical residues in which all single-base missense changes will disrupt protein function, and "spacer" residues in which the precise nature of the residue is unimportant but the peptide bond is necessary to keep the critical residues in register. More work is necessary to assess the veracity and generality of these ideas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634040     DOI: 10.1096/fasebj.6.10.1634040

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  12 in total

1.  A novel nonsense mutation in exon 2 of the factor IX gene resulting in severe haemophilia B.

Authors:  Marcello Niceta; Carmelo Fabiano; Pietro Sammarco; Fabio Gagliano; Giacomo Mancuso
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

2.  Unique amino acid signatures that are evolutionarily conserved distinguish simple-type, epidermal and hair keratins.

Authors:  Pavel Strnad; Valentyn Usachov; Cedric Debes; Frauke Gräter; David A D Parry; M Bishr Omary
Journal:  J Cell Sci       Date:  2012-01-03       Impact factor: 5.285

3.  Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation.

Authors:  R P Ketterling; E Vielhaber; C D Bottema; D J Schaid; M P Cohen; C L Sexauer; S S Sommer
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

4.  The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene.

Authors:  R P Ketterling; E Vielhaber; S S Sommer
Journal:  Am J Hum Genet       Date:  1994-05       Impact factor: 11.025

5.  The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA.

Authors:  J C Shen; W M Rideout; P A Jones
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

Review 6.  Epigenetics: A primer for clinicians.

Authors:  Benjamin E Paluch; Abdul R Naqash; Zachary Brumberger; Michael J Nemeth; Elizabeth A Griffiths
Journal:  Blood Rev       Date:  2016-02-26       Impact factor: 8.250

7.  Novel pattern of P53 mutation in breast cancers from Austrian women.

Authors:  A Hartmann; G Rosanelli; H Blaszyk; J M Cunningham; R M McGovern; J J Schroeder; D J Schaid; J S Kovach; S S Sommer
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

8.  The rates and patterns of deletions in the human factor IX gene.

Authors:  R P Ketterling; E L Vielhaber; T J Lind; E C Thorland; S S Sommer
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

9.  Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Investigation of the German haemophilia B population and review of de novo mutations.

Authors:  O Knobloch; B Zoll; K Zerres; H H Brackmann; K Olek; M Ludwig
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

10.  CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations.

Authors:  Y K Maliaka; A P Chudina; N F Belev; P Alday; N P Bochkov; J M Buerstedde
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.